Meeting
2021 ASCO Annual Meeting
Beyond steroids: Immunosuppressants in steroid-refractory/resistant immune related adverse events.
Authors
Jia Luo
Memorial Sloan Kettering Cancer Center, New York, NY
Jia Luo , Jason Beattie , Paige Fuentes , Hira Rizvi , Jacklynn V. Egger , Jeffrey Kern , Donald Y. M. Leung , Mario E. Lacouture , Mark G. Kris , Maya Gambarin , Bianca Santomasso , David M. Faleck , Matthew D. Hellmann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9092)
DOI
10.1200/JCO.2021.39.15_suppl.9092
Abstract #
9092
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Detection of immune-related adverse events among hospitalized patients using large language models.
First Author: Virginia H. Sun
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Immune-related adverse events in patients with gastrointestinal cancer undergoing pembrolizumab monotherapy: A systematic review of clinical trials.
First Author: Nikolas Naleid
Poster
2023 ASCO Annual Meeting
Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-cell lung cancer.
First Author: Jarushka Naidoo
Poster
2023 ASCO Annual Meeting
Association between physical activity, immune-related adverse events, and mortality in patients undergoing immune checkpoint inhibition.
First Author: Rik Jasper Verheijden